Depression screening tools in persons with epilepsy: A systematic review of validated tools

被引:116
作者
Gill, Stephanie J. [1 ,2 ]
Lukmanji, Sara [1 ,2 ]
Fiest, Kirsten M. [2 ,3 ,4 ,5 ]
Patten, Scott B. [2 ,3 ,4 ,6 ,7 ]
Wiebe, Samuel [1 ,2 ,3 ,4 ]
Jette, Nathalie [1 ,2 ,3 ,4 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[4] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada
[5] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada
[6] Univ Calgary, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada
[7] Univ Calgary, Dept Psychiat, Calgary, AB, Canada
关键词
Major depressive disorder; Mental health; Comorbidity; Diagnostic accuracy; Measurement; PATIENT HEALTH QUESTIONNAIRE-2; MAJOR DEPRESSION; HOSPITAL ANXIETY; NDDI-E; CHINESE VERSION; SPANISH VERSION; RAPID DETECTION; GERMAN VERSION; RATING-SCALE; PRIMARY-CARE;
D O I
10.1111/epi.13651
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Depression affects approximately 25% of epilepsy patients. However, the optimal tool to screen for depression in epilepsy has not been definitively established. The purpose of this study was to systematically review the literature on the validity of depression-screening tools in epilepsy. Methods: MEDLINE, EMBASE, and PsycINFO were searched until April 4, 2016 with no restriction on dates. Abstract, full-text review and data abstraction were conducted in duplicate. We included studies that evaluated the validity of depression-screening tools and reported measures of diagnostic accuracy (e.g., sensitivity, specificity, and negative and positive predictive values) in epilepsy. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies Version 2. Medians and ranges for estimates of diagnostic accuracy were calculated when appropriate. Results: A total of 16,070 abstracts were screened, and 38 articles met eligibility criteria. Sixteen screening tools were validated in 13 languages. The most commonly validated screening tool was the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) (n=26). The Mini International Neuropsychiatric Interview (MINI) (n=19) was the most common reference standard used. At the most common cutpoint of >15 (n=12 studies), the NDDI-E had a median sensitivity of 80.5% (range 64.0-100.0) and specificity of 86.2 (range 81.0-95.6). Meta-analyses were not possible due to variability in cutpoints assessed, reference standards used, and lack of confidence intervals reported. Significance: A number of studies validated depression screening tools; however, estimates of diagnostic accuracy were inconsistently reported. The validity of scales in practice may have been overestimated, as cutpoints were often selected post hoc based on the study sample. The NDDI-E, which performed well, was the most commonly validated screening tool, is free to the public, and is validated in multiple languages and is easy to administer, although selection of the best tool may vary depending on the setting and available resources.
引用
收藏
页码:695 / 705
页数:11
相关论文
共 72 条
  • [31] Combined detection of depression and anxiety in epilepsy patients using the Neurological Disorders Depression Inventory for Epilepsy and the World Health Organization well-being index
    Hansen, Christian Pilebaek
    Amiri, Moshgan
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 33 : 41 - 45
  • [32] Occurrence and Recurrence of Attempted Suicide Among People With Epilepsy
    Hesdorffer, Dale C.
    Ishihara, Lianna
    Webb, David J.
    Mynepalli, Lakshmi
    Galwey, NicholasW.
    Hauser, W. Allen
    [J]. JAMA PSYCHIATRY, 2016, 73 (01) : 80 - 86
  • [33] How do we measure psychiatric diagnoses? Implications of the choice of instruments in epilepsy
    Hesdorffer, Dale C.
    Baldin, Elisa
    Caplan, Rochelle
    Berg, Anne T.
    [J]. EPILEPSY & BEHAVIOR, 2014, 31 : 351 - 355
  • [34] Psychiatric disorders in children and adolescents who have epilepsy
    Jones, Jana E.
    Austin, Joan K.
    Caplan, Rochelle
    Dunn, David
    Plioplys, Sigita
    Salpekar, Jay A.
    [J]. PEDIATRICS IN REVIEW, 2008, 29 (02) : E9 - E14
  • [35] Clinical assessment of axis I psychiatric morbidity in chronic epilepsy: A multicenter investigation
    Jones, JE
    Hermann, BP
    Barry, JJ
    Gilliam, F
    Kanner, AM
    Meador, KJ
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 17 (02) : 172 - 179
  • [36] Screening for major depression in epilepsy with common self-report depression inventories
    Jones, JE
    Hermann, BP
    Woodard, JL
    Barry, JJ
    Gilliam, F
    Kanner, AM
    Meador, KJ
    Sheehan, DV
    Lecrubier, Y
    [J]. EPILEPSIA, 2005, 46 (05) : 731 - 735
  • [37] Measurement of Depression in Epilepsy
    Karzmark, Peter
    Zeifert, Penelope
    Barry, John
    [J]. EPILEPSY & BEHAVIOR, 2001, 2 (02) : 124 - 128
  • [38] Reliability and validity of the beck depression inventory-fast screen for medical patients in the general German population
    Kliem, Soeren
    Moessle, Thomas
    Zenger, Markus
    Braehler, Elmar
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2014, 156 : 236 - 239
  • [39] Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E)
    Ko, Pan-Woo
    Hwang, Jun
    Lim, Hye-Won
    Park, Sung-Pa
    [J]. EPILEPSY & BEHAVIOR, 2012, 25 (04) : 539 - 542
  • [40] Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: Results from the 2004 Healthstyles Survey
    Kobau, Rosemarie
    Gilliam, Frank
    Thurman, David J.
    [J]. EPILEPSIA, 2006, 47 (11) : 1915 - 1921